Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,058 JPY | -1.60% | -1.91% | -2.80% |
May. 13 | Ezaki Glico's Q1 Attributable Profit Climbs 21% on Higher Net Sales | MT |
Feb. 13 | Ezaki Glico's Profit Up 75% in Fiscal 2023 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- The company shows low valuation levels, with an enterprise value at 0.48 times its sales.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Most analysts recommend that the stock should be sold or reduced.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.80% | 1.68B | B+ | ||
-2.47% | 274B | A- | ||
-0.84% | 96.48B | C+ | ||
-2.41% | 43.95B | C+ | ||
+11.25% | 42.24B | B- | ||
+1.40% | 41.25B | B- | ||
+8.49% | 40B | B- | ||
-16.48% | 30.49B | B- | ||
-7.27% | 28.7B | A | ||
+13.65% | 25.55B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 2206 Stock
- Ratings Ezaki Glico Co., Ltd.